Sign in
Taking people in United StatesNo phase

Learning about the features of hidradenitis suppurativa, a skin disease

Follows people with hidradenitis suppurativa to learn about its features.

Key facts

Who runs it
University of California, San Francisco
Where
San Francisco, United StatesSee the site
Trial code
Registry title
Clinical and Biological Characteristics of Hidradenitis Suppurativa
Status
Recruiting
People taking part
1,000 people, planned
Started
15 Jul 2016
Planned end
15 Jul 2026
Type of study
Observational, 2 groups
Record updated
4 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with hidradenitis suppurativa (HS), a long-term skin disease, and healthy volunteers. It only observes and collects information and samples.

Age
13 years or older
Sex
All sexes
Disease stage
Patients: HS diagnosis confirmed by a doctor. Healthy volunteers: no history of long-term skin conditions.
Earlier treatment
Healthy volunteers cannot have used antibiotics recently.

Main reasons for not taking part

  • Not able to give informed consent, with no parent or guardian able and willing to consent
  • Healthy volunteers: any history of long-term skin conditions
  • Healthy volunteers: recent antibiotic use

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Age 13 years or older
  • Diagnosis of HS clinically-confirmed by a physician
  • No history of chronic skin conditions
  • No recent history of antibiotic use

Who cannot take part

  • Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent; Healthy Volunteer
  • Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent

Other criteria

  • Hidradenitis Suppurativa Patients

Where in United States

  • University of California San FranciscoSan Francisco, United StatesContact: Maia Paul, MPHTaking people

About the trial

What the trial wants to find out

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.

The 2 groups in the trial

  • Hidradenitis Suppurativa Patients

    Patients with physician diagnosed Hidradenitis Suppurativa

  • Healthy Volunteers

    Healthy volunteers without any skin conditions or recent history of antibiotic use.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Clinical and Biological Characteristics of Hidradenitis Suppurativa
Plain-language title
Learning about the features of hidradenitis suppurativa, a skin diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
4 May 2026